Dr. Toshihiko Doi, MD of National Cancer Center Hospital East, Japan discusses clinical trial efforts in UGI cancers with the anti-PD-1 and PD-L1 monoclonal antibodies at ASCO GI 2016
Dr. Toshihiko Doi, MD of National Cancer Center Hospital East, Japan discusses clinical trial efforts in UGI cancers with the anti-PD-1 and PD-L1 monoclonal antibodies at ASCO GI 2016